norbergenin

CAS No. 79595-97-4

norbergenin( —— )

Catalog No. M24794 CAS No. 79595-97-4

Norbergenin is a chemical compound. It is the O-demethylated derivative of bergenin. It can be isolated from rhizomes of Bergenia stracheyi.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 128 In Stock
5MG 112 In Stock
10MG 186 In Stock
25MG 317 In Stock
50MG 439 In Stock
100MG 625 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    norbergenin
  • Note
    Research use only, not for human use.
  • Brief Description
    Norbergenin is a chemical compound. It is the O-demethylated derivative of bergenin. It can be isolated from rhizomes of Bergenia stracheyi.
  • Description
    Norbergenin is a chemical compound. It is the O-demethylated derivative of bergenin. It can be isolated from rhizomes of Bergenia stracheyi.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    IL Receptor
  • Recptor
    IL receptor|TNF-α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    79595-97-4
  • Formula Weight
    314.25
  • Molecular Formula
    C13H14O9
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C1C2=CC(O)=C(O)C(O)=C2[C@@]3([H])[C@]([C@@H](O)[C@H](O)[C@@H](CO)O3)([H])O1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Nazir N , Koul S , Qurishi M A , et al. Immunomodulatory effect of bergenin and norbergenin against adjuvant-induced arthritis--a flow cytometric study.[J]. Journal of Ethnopharmacology, 2007, 112(2):401-405.
molnova catalog
related products
  • 5-O-Caffeoylshikimic...

    5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.

  • Rolinsatamab

    Rolinsatamab is a fully humanized selective monoclonal antibody that is a potent dual inhibitor of IL-4 and IL-13.

  • Canakinumab

    Canakinumab (ACZ885) is a recombinant human IL-1β-targeting monoclonal antibody that inhibits human and chorioallantoic monkey IL-1β with IC50 values of 43.6 and 40.8 pM, respectively.